Health Resources
Featured Centers
- Eating Out? Cut Calories, Heartburn
- 5 Good Ways to Save Money on Medicine
- 8 Ways to Treat Your Allergies
Parkinson's Disease Clinical Trials »
You may have heard about clinical trials from your doctor, read or heard advertisements in the newspaper or on the radio, or found out about trials in your area through a support group or association. Before you decide to participate in a trial, you should be aware of the potential benefits and risks. This guide provides a brief overview of the clinical trial process.
A clinical trial is a research program conducted in patients to evaluate a new medical treatment, drug, or device. The purpose of clinical trials is to find new and improved methods of treating diseases and special conditions.
During a clinical trial, doctors use the best available treatment as a standard to evaluate new treatments. The new treatments are hoped to be at least as effective as -- or possibly more effective than -- the standard.
New treatment options are ...
Medical Editor: John P. Cunha, DO, FACOEP
Azilect (rasagiline tablets) is used to treat the symptoms of Parkinson's disease. It is sometimes used with another drug called levodopa. Azilect is a monoamine oxidase-B (MAO-B) inhibitor. Common side effects include dizziness, joint pain, heartburn, nausea, fever, muscle pain, dry mouth, and stomach/abdominal pain.
The recommended dose of Azilect for the treatment of Parkinson's disease patients is 1 mg administered orally once daily. Azilect may interact with ciprofloxacin, theophylline, or antidepressants. Other drugs may affect Azilect. Tell your doctor all medications you use. During pregnancy, Azilect should be used only when prescribed. It is not known if this drug passes into breast milk. Consult your doctor before breast-feeding.
Our Azilect (rasagiline tablets) Drug Center provides a comprehensive view of available drug information as well as related drugs, user reviews, supplements, and diseases and conditions articles.
What is Prescribing information?
The FDA package insert formatted in easy-to-find categories for health professionals and clinicians.
AZILECT (rasagiline tablets) is indicated for the treatment of the signs and symptoms of idiopathic Parkinson's disease as initial monotherapy and as adjunct therapy to levodopa.
The effectiveness of AZILECT (rasagiline) was demonstrated in patients with early Parkinson's disease who were receiving AZILECT (rasagiline) as monotherapy and who were not receiving any concomitant dopaminergic therapy. The effectiveness of AZILECT (rasagiline) as adjunct therapy was demonstrated in patients with Parkinson's disease who were treated with levodopa.
Read the complete drug monograph for Azilect »
Drug Description - Indications & Dosage - Side Effects & Drug Interactions - Warnings & Precautions - Contraindications - Medication Guide and More
What is Patient information?
Easy-to-read and understand detailed drug information and pill images for the patient or caregiver from Cerner Multum.
Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Stop using rasagiline and call your doctor at once if you have any of these serious side effects:
Read the complete patient information for Azilect »
Possible Side Effects - Images - What Is - How Should I Take It - What If I Miss a Dose - What Should I Avoid and More
What is Consumer information?
A concise overview of the drug for the patient or caregiver from First DataBank.
Rasagiline is an enzyme blocker (MAO inhibitor) that works by slowing the breakdown of certain natural substances in the brain (neurotransmitters such as dopamine, norepinephrine, and serotonin).
...
Read the complete consumer information for Azilect »
Warnings - Uses - How to Use - Side Effects - Precautions - Drug Interactions and More
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get breaking medical news.